Comparison of Efficacy and Tolerability of APD Treatment With Different PD Cyclers
Sponsor: Fresenius Medical Care Deutschland GmbH
Listed as NCT04749680, this NA trial focuses on End Stage Renal Disease and Renal Failure and remains completed. Sponsored by Fresenius Medical Care Deutschland GmbH, it has been updated 6 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2022 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jan 2022 — Sep 2022 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2021 — Jan 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Mar 2021 — Sep 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Fresenius Medical Care Deutschland GmbH
- James Motta, Clinical Research Associate (CRA)
- Winicker Norimed GmbH
For direct contact, visit the study record on ClinicalTrials.gov .